Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Massive DC study aims to improve HIV care for 19,000 people

NCT ID NCT01206920

Knowledge-focused Sponsor: George Washington University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This long-term study follows 19,000 people with or at risk for HIV in Washington, DC to track their health outcomes and quality of care. Researchers will monitor viral suppression rates and new infections over up to 10 years. The goal is to find ways to improve HIV treatment and prevention across the city.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could reveal better ways to manage HIV care and prevent new infections across a whole city.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly test new drugs or cures. Results may take years and might not apply to other cities.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 19,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2011

Expected to finish

Jan 2041

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Study participants will include men, women and children receiving HIV prevention, care or treatment services at major publicly-funded, government and academic medical centers in the District of Columbia.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Treatment Cohort Inclusion Criteria: * Patient is receiving care for HIV at one or more of the twelve participating clinics in the DC Cohort. * Patient is either age 18 years or older, or seeks HIV care independently and is able to understand and sign informed consent. * Patient is a minor who is consented by a parent or legal guardian. Treatment Cohort Exclusion Criteria: * Patient is unable or refuses to provide informed consent. * Minor children ages 12 through 17 who are unaware of their HIV status Prevention Cohort Inclusion Criteria: Persons receiving any antiretroviral prescription without evidence of HIV or Hepatitis B infection * PrEP (e.g., TDF/FTC, Descovy, Apretude) * Combination ART indicative of nPEP in an HIV-uninfected person * Persons receiving an antiretroviral prescription indicative of DoxyPEP Doxycycline 200mg PO taken within 72 hrs of unprotected sexual encounter (or variations thereof where clearly not prescribed as a treatment course) * Test positive for ≥1 bacterial STI (positive gonorrhea (GC/NG) or chlamydia (CT) test or positive syphilis test requiring treatment within one year) * 2 bacterial STI (GC, chlamydia, syphilis) tests at 2 or more different encounters * 2 HIV tests at 2 or more different encounters * Patient requesting PrEP at their clinical visit * Patient requesting nPEP at their clinical visit * People who identify as injecting drugs Patients with a Z29.81 Encounter for HIV pre-exposure prophylaxis

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AIDS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

AIDS HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AIDS HIV

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    14 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Children's National Medical Center--Pediatric Clinic

    RECRUITING

    Washington D.C., District of Columbia, 20010, United States

  • Family and Medical Counseling Service

    RECRUITING

    Washington D.C., District of Columbia, 20020, United States

  • George Washington Medical Faculty Associates

    RECRUITING

    Washington D.C., District of Columbia, 20037, United States

  • Georgetown University

    RECRUITING

    Washington D.C., District of Columbia, 20007, United States

  • Howard University Hospital--Adult Clinic

    RECRUITING

    Washington D.C., District of Columbia, 20060, United States

  • Howard University Hospital--Pediatric Clinic

    RECRUITING

    Washington D.C., District of Columbia, 20060, United States

  • Kaiser Permanente Mid-Atlantic States

    RECRUITING

    Washington D.C., District of Columbia, 20002, United States

  • La Clinica Del Pueblo

    RECRUITING

    Washington D.C., District of Columbia, 20009, United States

  • Unity Health Care

    RECRUITING

    Washington D.C., District of Columbia, 20003, United States

  • Us Helping Us, People into Living, Inc.

    RECRUITING

    Washington D.C., District of Columbia, United States

  • Veterans Affairs Medical Center

    RECRUITING

    Washington D.C., District of Columbia, 20422, United States

  • Washington Health Institute

    RECRUITING

    Washington D.C., District of Columbia, 20017, United States

  • Washington Hospital Center

    RECRUITING

    Washington D.C., District of Columbia, 20010, United States

  • Whitman-Walker Health

    RECRUITING

    Washington D.C., District of Columbia, 20009, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.